HTG Molecular Diagnostics (HTGMQ) Earnings Date, Estimates & Call Transcripts $0.0013 -0.01 (-82.67%) (As of 03:30 PM ET) Add Compare Share Share Today's Range$0.0013▼$0.001350-Day Range$0.00▼$0.3752-Week Range$0.00▼$23.64Volume304 shsAverage Volume246,930 shsMarket Capitalization$2,873.00P/E RatioN/ADividend YieldN/APrice TargetN/A EarningsStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueHTGMQ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HTGMQ Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. HTG Molecular Diagnostics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/10/2023Q1 2023($1.94)($2.28)($0.34)($2.28)$1.60 million$1.03 million11/10/2022Q3 2022($6.24)($4.92)+$1.32($4.92)$2.25 million$1.25 million8/11/2022Q2 2022($6.96)($6.48)+$0.48($6.48)$2.20 million$1.49 million5/12/2022Q1 2022($8.52)($9.72)($1.20)($9.72)$1.40 million$1.18 million3/29/2022Q4 2021($7.44)($8.28)($0.84)($8.28)$2.90 million$2.88 million11/10/2021Q3 2021($7.20)($7.20)-($7.20)$2.90 million$2.52 million Get the Latest News and Ratings for HTGMQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2021Q2 2021($9.48)($7.20)+$2.28($9.72)$2.16 million$2.07 million5/13/2021Q1 2021($11.40)($9.60)+$1.80($9.60)$1.40 million$1.44 million HTG Molecular Diagnostics Earnings - Frequently Asked Questions How much revenue does HTG Molecular Diagnostics generate each year? HTG Molecular Diagnostics (NASDAQ:HTGMQ) has a recorded annual revenue of $6.37 million. How much profit does HTG Molecular Diagnostics generate each year? HTG Molecular Diagnostics (NASDAQ:HTGMQ) has a recorded net income of -$21.59 million. HTGMQ has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: VRAYQ Earnings PRPO Earnings TLIS Earnings OMIC Earnings RPID Earnings HLTH Earnings BNGO Earnings AXDX Earnings SEER Earnings LAB Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: The truth about Lululemon earnings: Suddenly in bearish crosshairOwn Dollar General? Hurry and take this advice before earningsEarnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Hims & Hers earnings highlight expanded personalized treatmentsCan Kohl's keep its momentum after earnings dip? This page (NASDAQ:HTGMQ) was last updated on 12/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HTG Molecular Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.